Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather busy for a change. We plan to collect our shortest person from an institution of higher learning, tend to the Pharmalot grounds, promenade with the official mascot, and indulge Mrs. Pharmalot. And what about you? This is a fine time to enjoy the great outdoors — a drive in the country, a walk in the park, a hike in the hills. Take your pick. This may be an opportunity to catch up on the news of the world, such as it is. Or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. And wherever Mom may be, remember to say hi. Enjoy, and see you soon. …

The U.S. Food and Drug Administration is limiting access to the Johnson & Johnson Covid-19 vaccine because of the risk of a blood-clotting disorder that was discovered weeks after the vaccine was first put into use in the spring of 2021, STAT tells us. Going forward, the single-dose shot will be available only to people 18 and older who cannot take one of the other available vaccines for medical reasons, or who simply will not agree to be vaccinated with one of the messenger RNA vaccines made by Moderna and by Pfizer and its partner BioNTech. The decision followed a recent review of data showing a ninth person in the U.S. died after receiving the shot. This occurred in the first quarter of the year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment